Sandra Sanabria Email and Phone Number

Sandra has 24 years’ experience in the pharmaceutical industry and is a recognized expert, applying Nuclear Medicine to drug research and development and successfully translating PET imaging biomarkers for assessment of target engagement and disease progression in Neurosciences and Oncology clinical studies. Qualification Highlights:• Comprehensive understanding and proficiency in designing and conducting clinical imaging studies for both observational and interventional clinical trials.• Proven track record of selecting, collaborating with, and overseeing imaging commercial research organizations (CROs).• Significant expertise in the utilization of small molecule and biologics PET/SPECT imaging in drug discovery and development.• Extensive experience in creating tools for processing and analyzing PET/SPECT imaging data, including kinetic modeling and quantification. • Exceptional communication skills. • Exemplary aptitude for thriving within multi-disciplinary team environments.My career goal is to contribute to the discovery and development of interventions aimed at tackling neurodegenerative diseases and cancer. By actively engaging in multi-disciplinary teams, I aspire to contribute my expertise, gained by working with imaging biomarkers, in a way that fosters holistic and innovative approaches to unraveling the complexities of these conditions, enabling early detection, precise monitoring, and the assessment of therapeutic efficacy. Through effective teamwork, I aim to make meaningful contributions that advance our collective understanding and treatment capabilities and ultimately improving the lives of individuals affected by them.